1. Home
  2. ARQQ vs CCEL Comparison

ARQQ vs CCEL Comparison

Compare ARQQ & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arqit Quantum Inc.

ARQQ

Arqit Quantum Inc.

HOLD

Current Price

$24.28

Market Cap

465.3M

Sector

Technology

ML Signal

HOLD

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

N/A

Current Price

$3.86

Market Cap

32.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARQQ
CCEL
Founded
2017
1989
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Managed Health Care
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
465.3M
32.7M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
ARQQ
CCEL
Price
$24.28
$3.86
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$60.00
N/A
AVG Volume (30 Days)
387.3K
3.5K
Earning Date
12-09-2025
10-15-2025
Dividend Yield
N/A
10.34%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$530,000.00
$31,747,500.00
Revenue This Year
$183.60
$0.30
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.00
$3.57
52 Week High
$62.00
$8.79

Technical Indicators

Market Signals
Indicator
ARQQ
CCEL
Relative Strength Index (RSI) 36.32 44.15
Support Level $27.50 $3.74
Resistance Level $30.45 $4.38
Average True Range (ATR) 2.36 0.26
MACD 0.10 -0.01
Stochastic Oscillator 8.15 34.83

Price Performance

Historical Comparison
ARQQ
CCEL

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: